BIOMAT Database Logo BIOMAT Database Logo

Preliminary observations on a new antiarrhythmic agent (Ro 2-5803). 1960

A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF

UI MeSH Term Description Entries
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
Preliminary evaluation of Ro 2-5803--an antiarrhythmic agent.
June 1960, The American journal of cardiology,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
[Experiences with a new anti-arrhythmic agent, Ro 2-5803].
July 1962, Ugeskrift for laeger,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
A new anti-arrhythmia agent (Ro 2-5803): its effect on ventricular arrhythmias.
June 1961, Journal of the American Geriatrics Society,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
Preliminary observations on a new derivative of isoniazid (Ro 2-4969).
November 1953, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
Electropharmacology of Ro 22-9194, a new antiarrhythmic agent.
July 1996, General pharmacology,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
[CLINICAL AND EXPERIMENTAL STUDY OF A SYNTHETIC ANTI-ARRHYTHMIA AGENT: RO 2-5803. ITS EFFECTS IN VENTRICULAR EXTRASYSTOLE].
January 1964, Acta cardiologica,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
Preliminary report on Ro 5-3307/1, a new antihypertensive agent.
July 1963, Journal - Newark Beth Israel Hospital,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
[PRELIMINARY OBSERVATIONS ON A NEW HYPOTENSIVE AGENT: METHYLDOPA].
June 1963, Revista brasileira de medicina,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
Initial clinical experience of lorcainide (Ro 13-1042), a new antiarrhythmic agent.
November 1978, European journal of clinical pharmacology,
A N BREST, and J STRAUGHN, and A SINGER, and W LIKOFF
[Preliminary clinical observations on a new benzodiazepin derivative Ro 5-4556].
May 1968, Hospital (Rio de Janeiro, Brazil),
Copied contents to your clipboard!